| Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population SL Klein, A Pekosz, HS Park, RL Ursin, JR Shapiro, SE Benner, ... The Journal of clinical investigation 130 (11), 6141-6150, 2020 | 456 | 2020 |
| Stop ‘controlling’for sex and gender in global health research JR Shapiro, SL Klein, R Morgan BMJ Global Health 6 (4), e005714, 2021 | 56 | 2021 |
| Beyond a zero-sum game: how does the impact of COVID-19 vary by gender? R Morgan, P Baker, DM Griffith, SL Klein, CH Logie, AA Mwiine, ... Frontiers in Sociology 6, 650729, 2021 | 50 | 2021 |
| Differences and disparities in seasonal influenza vaccine, acceptance, adverse reactions, and coverage by age, sex, gender, and race A Kini, R Morgan, H Kuo, P Shea, J Shapiro, SX Leng, A Pekosz, SL Klein Vaccine 40 (11), 1643-1654, 2022 | 41 | 2022 |
| Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008–2011 NL Gilbert, J Rotondo, J Shapiro, L Sherrard, WD Fraser, BJ Ward Vaccine 35 (23), 3050-3055, 2017 | 32 | 2017 |
| Association of frailty, age, and biological sex with severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine–induced immunity in older adults JR Shapiro, I Sitaras, HS Park, TY Aytenfisu, C Caputo, M Li, J Lee, ... Clinical Infectious Diseases 75 (Supplement_1), S61-S71, 2022 | 24 | 2022 |
| Sex-specific effects of aging on humoral immune responses to repeated influenza vaccination in older adults JR Shapiro, H Li, R Morgan, Y Chen, H Kuo, X Ning, P Shea, C Wu, ... npj Vaccines 6 (1), 147, 2021 | 23 | 2021 |
| Sex-specific effects of age and body mass index on antibody responses to seasonal influenza vaccines in healthcare workers H Kuo, JR Shapiro, S Dhakal, R Morgan, AL Fink, H Liu, JW Westerbeck, ... Vaccine 40 (11), 1634-1642, 2022 | 22 | 2022 |
| Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection HS Park, JR Shapiro, I Sitaras, BA Woldemeskel, CC Garliss, A Dziedzic, ... JCI insight 7 (5), 2022 | 17 | 2022 |
| Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial. S Shoham, EM Bloch, A Casadevall, D Hanley, B Lau, K Gebo, E Cachay, ... Clin. infect. dis, 2022 | 17 | 2022 |
| Needle-free delivery of influenza vaccine using the Med-Jet® H4 is efficient and elicits the same humoral and cellular responses as standard IM injection: A randomized trial JR Shapiro, B Hodgins, HE Hendin, A Patel, K Menassa, C Menassa, ... Vaccine 37 (10), 1332-1339, 2019 | 17 | 2019 |
| COVID-19: use intersectional analyses to close gaps in outcomes and vaccination. JR Shapiro, SL Klein, R Morgan Nature 591 (7849), 202-202, 2021 | 15 | 2021 |
| Sex-biased immune responses following SARS-CoV-2 infection RL Ursin, JR Shapiro, SL Klein Trends in Microbiology 28 (12), 952-954, 2020 | 14 | 2020 |
| Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults JR Shapiro, HS Park, TY Aytenfisu, C Caputo, J Lee, TS Johnston, H Li, ... medRxiv, 2022.03. 11.22272269, 2022 | 12 | 2022 |
| Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection S Shoham, EM Bloch, A Casadevall, D Hanley, B Lau, K Gebo, E Cachay, ... medRxiv, 2021 | 12 | 2021 |
| The intersection of gender and race in older adults’ decision to receive COVID-19 vaccines JR Shapiro, L Privor-Dumm, EN Rosser, SX Leng, SL Klein, R Morgan Vaccine 41 (1), 211-218, 2023 | 11 | 2023 |
| Transfusing convalescent plasma as post-exposure prophylaxis against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a double-blinded, phase 2 … S Shoham, EM Bloch, A Casadevall, D Hanley, B Lau, K Gebo, E Cachay, ... Clinical infectious diseases 76 (3), e477-e486, 2023 | 9 | 2023 |
| Roadmap for sex-responsive influenza and COVID-19 vaccine research in older adults JR Shapiro, R Morgan, SX Leng, SL Klein Frontiers in Aging 3, 836642, 2022 | 9 | 2022 |
| Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in adult patients with immune-mediated inflammatory diseases MW Cheung, RM Dayam, JR Shapiro, JC Law, GYC Chao, D Pereira, ... The Journal of Immunology Author Choice 211 (3), 351, 2023 | 7 | 2023 |
| Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization SA McConnell, J Sachithanandham, NJ Mudrak, X Zhu, PA Farhang, ... Cell Chemical Biology 30 (7), 726-738. e4, 2023 | 6 | 2023 |
